# Open-label Adjunctive Zonisamide for Bipolar Disorder

> **NCT00047567** · PHASE4 · TERMINATED · sponsor: **Elan Pharmaceuticals** · enrollment: 20 (—)

## Conditions studied

- Bipolar Disorders

## Interventions

- **DRUG:** zonisamide

## Key facts

- **NCT ID:** NCT00047567
- **Lead sponsor:** Elan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2002-07
- **Target enrollment:** 20 (—)
- **Last updated:** 2015-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047567, "Open-label Adjunctive Zonisamide for Bipolar Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00047567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*